Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ONDO INSURTECH PLC Director's Dealing 2025

Feb 5, 2025

5074_dirs_2025-02-05_b10dd498-6b5d-4009-bbf6-a2f972bba4d6.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0435W

Ondo InsurTech PLC

05 February 2025

5 February 2025

Ondo InsurTech Plc

("Ondo" or the "Company")

Exercise of Warrants and Director/PDMR Shareholding

Ondo InsurTech Plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that Craig Foster, Chief Executive Officer of the Company, has exercised warrants to subscribe for 889,783 ordinary shares of 5 pence each ("Ordinary Shares") at an exercise price of 25 pence each (the "Warrants") and will be admitted to the Official List under the Ondo block listing.

The Company also announces that Criag Foster has sold 700,000 Ordinary Shares at an average price of 37p per share, the proceeds of which will be applied to meet in part the exercise of the Warrants and the resulting tax liability.

Following the exercise of the Warrants and the sale of Ordinary Shares Craig Foster's interest in the Company has increased by 189,783 Ordinary Shares and he now holds 2,182,341 Ordinary Shares representing 1.7% of the Company's issued share capital.

Enquiries

Ondo InsurTech Plc Craig Foster, CEO

Kevin Withington, CFO
+44 (0) 800 783 9866
Dowgate Capital Ltd

(Broker & Financial Advisor)
Russell Cook

Nick Chambers

Charlie Hall
+44 (0) 20 3903 7715
Cassiopeia Services Ltd

(PR & Investor Relations)
Stefania Barbaglio +44 (0) 7949 690338

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Craig Foster
2 Reason for the notification
a) Position/status Chief Executive Officer and PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Ondo InsurTech Plc
b) LEI 2138005Y5QBJQMOOI719
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 5 pence each

ISIN: GB00BNVVGD77
b) Nature of the transaction Exercise of Warrants
c) Price(s) and volume(s) Exercise of Warrants over 889,783 Ordinary Shares at an exercise price of 25p per warrant
d) Aggregated information
e) Date of the transaction 5 February 2025
f) Place of the transaction Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Craig Foster

2

Reason for the notification

a)

Position/status

Chief Executive Officer and PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Sale of ordinary shares of 5 pence each

ISIN: GB00BNVVGD77

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Prices Volumes
37.00p 700,000

d)

Aggregated information

e)

Date of the transaction

31 January 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFELFBELLZBBL